SPACInsider Logo
Falcon Capital Acquisition Corp. (FCAC) Shareholders Approve Sharecare Deal
by Marlena Haddad on 2021-06-29 at 5:43pm

Falcon Capital Acquisition Corp.  (NASDAQ:FCAC) announced in a press release  as well as in an 8-K filing today that its shareholders approved its combination with digital healthcare firm Sharecare at a special meeting held today.

The press release and 8-K did not mention redemptions, but noted that more than 97% of the votes cast, or 32,080,366 votes, at the meeting were in favor of the approval of the business combination. Investors reacted well to the news as FCAC rose 6.70% in post-market trading following the announcement.

Falcon shareholders also voted overwhelmingly to approve the other proposals which included to amend and restate the amended and restated certificate of incorporation to include a certificate of designations for the Series A Preferred Stock, change the name to Sharecare, Inc. and increase the authorized number of shares to 615,000,000. Additionally, shareholders approved the proposal to issue certain securities and the new incentive plan.

The transaction is expected to close on Thursday, July 1 and the combined company’s stock and warrants will start trading on the Nasdaq under the new symbols “SHCR” and “SHCRW”, respectively, on Friday, July 2.

Falcon Capital announced the $3.9 billion deal with Sharecare on February 12. Sharecare provides a patient-communication and digital health platform to insurers and healthcare providers.

For a full list of proposals and vote tallies, click HERE.


  • Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC acted as financial advisors to Sharecare
  • King & Spalding LLP acted as legal counsel to Sharecare
  • Goldman Sachs Group acted as financial advisor to Falcon Capital Acquisition Corp
  • White & Case LLP acted as legal counsel to Falcon Capital Acquisition Corp
  • Goldman Sachs and J.P. Morgan Securities LLC acted as joint placement agents in connection with the PIPE offering
Recent Posts
by Sam Beattie on 2022-12-02 at 7:10pm

Terms Tracker for the Week Ending December 2nd, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As we slide into December, and the holiday season, we recognized two new S-1 registration statements and zero IPOs. The two new S-1s consisted of...

by Marlena Haddad on 2022-12-02 at 5:38pm

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC Liquidations: NightDragon, VectoIQ II, and Fortistar Sustainable Solutions Corp. Night Dragon Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination NightDragon Acquisition Corp. (NASDAQ: NDAC) anticipates that the last trading day...

by Marlena Haddad on 2022-12-02 at 4:38pm

Lakeshore Acquisition I Corp. (NASDAQ:LAAA) disclosed this afternoon that its shareholders have approved its business combination with medical device company ProSomnus during a special meeting held earlier today. Approximately 92.4% of the votes cast at the meeting on the business combination proposal, representing approximately 80.5% of Lakeshore’s outstanding shares, voted to approve the deal. The SPAC disclosed...

by Marlena Haddad on 2022-12-02 at 11:38am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Embark director Elaine Chao and others sued over SPAC merger, Alvotech switches CEO and takes COO from Teva, and Uber Freight and Aurora expand pilot  Embark Director Elaine Chao, Others Sued Over SPAC...

by Nicholas Alan Clayton on 2022-12-02 at 7:51am

SPACInsider contributors Anthony Sozzi and Sam Beattie this week compiled their three favorite potential SPAC targets among potential targets in the security industry. We look at why they are compelling and why each could be a fit for a blank-check merger. Security is on the market’s mind and is expected to grow at a CAGR...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved